TET2 c.5422A>G ;(p.R1808G)

Variant ID: 4-106197089-A-G

NM_001127208.2(TET2):c.5422A>G;(p.R1808G)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.

Genome Medicine
Creaney, Jenette J; Patch, Ann-Marie AM; Addala, Venkateswar V; Sneddon, Sophie A SA; Nones, Katia K; Dick, Ian M IM; Lee, Y C Gary YCG; Newell, Felicity F; Rouse, Ebony J EJ; Naeini, Marjan M MM; Kondrashova, Olga O; Lakis, Vanessa V; Nakas, Apostolos A; Waller, David D; Sharkey, Annabel A; Mukhopadhyay, Pamela P; Kazakoff, Stephen H SH; Koufariotis, Lambros T LT; Davidson, Aimee L AL; Ramarao-Milne, Priya P; Holmes, Oliver O; Xu, Qinying Q; Leonard, Conrad C; Wood, Scott S; Grimmond, Sean M SM; Bueno, Raphael R; Fennell, Dean A DA; Pearson, John V JV; Robinson, Bruce W BW; Waddell, Nicola N
Publication Date: 2022-05-30

Variant appearance in text: TET2: 5422A>G
PubMed Link: 35637530
Variant Present in the following documents:
  • 13073_2022_1060_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page